Anoro Ellipta Inhaler

Uses of Anoro Ellipta Inhaler

Anoro Ellipta Inhaler is a form of powder inhaler that treats an obstruction of the airway. It is commonly known by its generic name Umeclidinium and Vilanterol.

Anoro Ellipta Inhaler is specifically designed to diminish COPD types of conditions, such as emphysema and bronchitis. COPD is defined as chronic obstructive pulmonary disease.

Use this inhalation powder to provide medical relief to individuals with COPD, not to alleviate signs of asthma. Its main components are umeclidinium and vilanterol.

Precautions and Warnings

As mentioned, this medication is not used to treat asthma. If a person has a sudden asthma attack, Anoro Ellipta shouldn’t be administered as it is not a fast-acting formula or medicine. It is only made to control and manage COPD.

If you are hypersensitive to Anoro Ellipta, most especially to its components, avoid taking the inhalation powder. If your breathing concerns are not improved, seek medical aid immediately.

Dosage

Administer Anoro Ellipta only once a day. Inhalation is done orally, with a 62.5 mcg pack size. Note that the inhalation activity must be in line with the doctors’ prescription, which possibly includes consuming the powder at the same time each day. Avoid using the medicine more than what you are directed to do.

Side Effects

Anoro Ellipta can cause serious adverse reactions if the prescription is not followed properly. Other than that, the following list includes the effects of using this medicine.

Common side effects:

• Stuffy nose
• Sinusitis
• Sore throat
• Cough
• Chest pain
• Mild diarrhea
• Constipation

Severe side effects:

• Breathing difficulty
• Pain during urination
• Blurry vision
• Eye pain
• Increased hunger
• Dryness of the mouth
• Severe constipation
• Irregular heartbeat
• Numbness
• Muscle weakness

More information about Anoro Ellipta Inhaler

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide